ReP USP - Resultado da busca

Filtros : "VÍRUS DE RNA" "BOSCARDIN, SILVIA BEATRIZ" Limpar

Filtros

USP affiliated authors
- boscardin, silvia beatriz (2)
- alves, rúbens prince dos santos (1)
- amarante, maria fernanda de castro (1)
- favaro, marianna teixeira de pinho (1)
- ferreira, luis carlos de souza (1)

Indexado em
Collaboration
Normalized affiliation
Non normalized affiliation
- centre for innovative cancer research, ottawa hospital research institute, ottawa, on, canada (1)
- clinical hospital hcfmusp, faculty of medicine, university of são paulo, são paulo, brazil (1)
- department of biochemistry, microbiology and immunology, university of ottawa, ottawa, on, canada (1)
- department of microbiology, institute of biomedical sciences, university of são paulo, são paulo, brazil (1)
- department of parasitology, institute of biomedical sciences, university of são paulo, são paulo, brazil (1)

Artigo de periodico
Intradermal delivery of dendritic cell-targeting chimeric mAbs genetically fused to type 2 Dengue virus nonstructural protein 1 (2020)
Pereira, Lennon Ramos ; Vicentin, Elaine Cristina Matos; Pereira, Sara Araujo ; Maeda, Denicar Lina Nascimento Fabris; Alves, Rubens Prince dos Santos ; Santos, Robert Andreata ; Sousa, Francielle Tramontini Gomes de ; Yamamoto, Marcio Massao ; Amarante, Maria Fernanda Castro ; Favaro, Marianna Teixeira de Pinho ; Romano, Camila Malta ; Sabino, Ester Cerdeira ; Boscardin, Silvia Beatriz ; Ferreira, Luís Carlos de Souza
Source: Vaccines. Unidades: ICB, FM
Subjects: PARASITOLOGIA, MICROBIOLOGIA, VÍRUS DA DENGUE, CÉLULAS DENDRÍTICAS, ANTICORPOS MONOCLONAIS, IMUNOGENÉTICA, IMUNOGENICIDADE DA VACINA, VACINAS VIRAIS, FLAVIVIRUS, VÍRUS DE RNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Lennon Ramos et al. Intradermal delivery of dendritic cell-targeting chimeric mAbs genetically fused to type 2 Dengue virus nonstructural protein 1. Vaccines, v. 8, p. 19 , 2020Tradução . . Disponível em: https://doi.org/10.3390/vaccines8040565. Acesso em: 17 nov. 2024.
APA
Pereira, L. R., Vicentin, E. C. M., Pereira, S. A., Maeda, D. L. N. F., Alves, R. P. dos S., Santos, R. A., et al. (2020). Intradermal delivery of dendritic cell-targeting chimeric mAbs genetically fused to type 2 Dengue virus nonstructural protein 1. Vaccines, 8, 19 . doi:10.3390/vaccines8040565
NLM
Pereira LR, Vicentin ECM, Pereira SA, Maeda DLNF, Alves RP dos S, Santos RA, Sousa FTG de, Yamamoto MM, Amarante MFC, Favaro MT de P, Romano CM, Sabino EC, Boscardin SB, Ferreira LC de S. Intradermal delivery of dendritic cell-targeting chimeric mAbs genetically fused to type 2 Dengue virus nonstructural protein 1 [Internet]. Vaccines. 2020 ; 8 19 .[citado 2024 nov. 17 ] Available from: https://doi.org/10.3390/vaccines8040565
Vancouver
Pereira LR, Vicentin ECM, Pereira SA, Maeda DLNF, Alves RP dos S, Santos RA, Sousa FTG de, Yamamoto MM, Amarante MFC, Favaro MT de P, Romano CM, Sabino EC, Boscardin SB, Ferreira LC de S. Intradermal delivery of dendritic cell-targeting chimeric mAbs genetically fused to type 2 Dengue virus nonstructural protein 1 [Internet]. Vaccines. 2020 ; 8 19 .[citado 2024 nov. 17 ] Available from: https://doi.org/10.3390/vaccines8040565
Artigo de periodico
Oncolytic rhabdovirus vaccine boosts chimeric Anti-DEC205 priming for effective cancer immunotherapy (2020)
Tzelepis, Fanny ; Birdi, Harsimrat Kaur ; Jirovec, Anna ; Boscardin, Silvia Beatriz ; Souza, Christiano Tanese de; Hooshyar, Mohsen; Chen, Andrew; Sutherland, Keara; Parks, Robin J.; Werier, Joel; Diallo, Jean-Simon
Source: Molecular Therapy - Oncolytics. Unidade: ICB
Subjects: PARASITOLOGIA, IMUNOTERAPIA, VACINAS VIRAIS, RHABDOVIRIDAE, VÍRUS DE RNA, NEOPLASIAS, VETORES, ANTÍGENOS DE VÍRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TZELEPIS, Fanny et al. Oncolytic rhabdovirus vaccine boosts chimeric Anti-DEC205 priming for effective cancer immunotherapy. Molecular Therapy - Oncolytics, v. 19, p. 240-252, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.omto.2020.10.007. Acesso em: 17 nov. 2024.
APA
Tzelepis, F., Birdi, H. K., Jirovec, A., Boscardin, S. B., Souza, C. T. de, Hooshyar, M., et al. (2020). Oncolytic rhabdovirus vaccine boosts chimeric Anti-DEC205 priming for effective cancer immunotherapy. Molecular Therapy - Oncolytics, 19, 240-252. doi:10.1016/j.omto.2020.10.007
NLM
Tzelepis F, Birdi HK, Jirovec A, Boscardin SB, Souza CT de, Hooshyar M, Chen A, Sutherland K, Parks RJ, Werier J, Diallo J-S. Oncolytic rhabdovirus vaccine boosts chimeric Anti-DEC205 priming for effective cancer immunotherapy [Internet]. Molecular Therapy - Oncolytics. 2020 ; 19 240-252.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.omto.2020.10.007
Vancouver
Tzelepis F, Birdi HK, Jirovec A, Boscardin SB, Souza CT de, Hooshyar M, Chen A, Sutherland K, Parks RJ, Werier J, Diallo J-S. Oncolytic rhabdovirus vaccine boosts chimeric Anti-DEC205 priming for effective cancer immunotherapy [Internet]. Molecular Therapy - Oncolytics. 2020 ; 19 240-252.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.omto.2020.10.007

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024